An important part of clinical study reporting, safety narratives should be prepared for all phases of clinical studies, whether conducted in healthy volunteers or in patients with the disease/condition under study. In her paper, Yvonne Moores of Quanticate describes current regulatory requirements with regard to safety narratives and a proposed process for their development and review, and examines ways to simplify the reporting process, thereby reducing the burden of time and cost.